Electra Secures 100% of Cobalt Feedstock Required for Refinery Commissioning and Ramp-Up
Extended Glencore agreement provides long-term feedstock supply through 2031 as Electra advances toward mechanical completion in 2027 TORONTO,…
Swiss Water Announces TSX Approval for Share Buyback under an NCIB
VANCOUVER, British Columbia, Aug. 17, 2026 (GLOBE NEWSWIRE) — Swiss Water Decaffeinated Coffee Inc. (TSX:SWP) (“Swiss Water” or…
Roche purchases shares in tender offer for 89bio, Inc
Basel, 30 October 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche’s wholly owned subsidiary…
Chubb Life Hong Kong Launches Critical Illness Plans with Market-First Features and Broader Protection for Customers with Diverse Health Needs
Chubb Care Critical Illness Series offers comprehensive protection for healthy individuals, cancer survivors and individualswith cardiovascular disease or…
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient population PSMAddition updated results show Pluvicto…
CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD)
Susvimo is the first and only continuous delivery treatment that offers an alternative to standard of care eye…
PharmaBlock Convenes Global Industry Leaders in Zurich to Advance Green Chemistry for Sustainable Pharmaceutical Manufacturing
ZURICH, July 20, 2026 /PRNewswire/ — As Europe experienced one of its hottest Junes on record, with prolonged…
Roche receives CE Mark for blood test to identify tuberculosis infection
The Elecsys IGRA TB test expands global access to tuberculosis infection testing, advancing progress toward the World Health…
Myricx Bio to be Acquired by Novartis to Advance Next-Generation ADC Payloads for Oncology with Novel NMTi Platform
Potential first-in-class N-myristoyltransferase inhibitor (NMTi) ADC payload with a differentiated mechanism of actionCombines oncology expertise of Novartis with…
Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics
MELBOURNE, Australia, July 06, 2026 (GLOBE NEWSWIRE) — Brandon Capital, Australasia’s leading life sciences venture capital firm, today…
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
First gene replacement therapy in the EU for broad population with SMA, including children two years and older,…
Name Change Completed for C Capital’s Swiss Listed Entity, Ticker Symbol CCAP Goes Live
HONG KONG, June 27, 2026 /PRNewswire/ — Youngtimers AG (Swiss Stock Exchange: YTME), a company listed on the…